Search

MS Forum® 2021, Session 2 – April 24

Date And Time

Sat, April 24, 2021
11:00 AM – 1:00 PM EDT

Course Chair

Patricia K. Coyle, MD, FAAN, FANA
Professor and Vice Chair (Clinical Affairs)
Department of Neurology
Director
Multiple Sclerosis Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, NY

Faculty

Bruce A. Cohen, MD, FAAN, FANA, FACP
Professor of Neurology
Northwestern University
Feinberg School of Medicine
Director
Northwestern Comprehensive Multiple Sclerosis Program
Chicago, IL

Clyde E. Markowitz, MD
Associate Professor of Neurology
Director, Multiple Sclerosis Center
Hospital of the University of Pennsylvania
Perelman School of Medicine
Philadelphia, PA

Agenda

  • Updates in Progressive MS: Differential Recognition and Management
  • Clinical Case 1: Progressive MS
  • Advances in MS: Environmental Factors and Comorbidities in MS
  • Point-Counterpoint: Rapid-Fire Controversies in MS
  • Clinical Case 2: Bringing it All Together
  • LIVE Question and Answer

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

Physician & Nurse

  • Evaluate the latest clinical and/or real-world evidence regarding available and emerging DMTs for MS management.
  • Assess the burden of comorbidities for patients with MS and implications for treatment, medication management, and quality of life.
  • Examine emerging clinical trends and controversies in MS that may impact future clinical decision-making.

Physician

  • Identify patients with relapsing-remitting MS (RRMS) or progressive MS in a timely manner to ensure appropriate intervention.
  • Select treatment for patients with RRMS or progressive MS based on the latest clinical advances, patient risk, and evidence-based recommendations.

Target Audience

The intended audience for this activity is neurologists, neurology nurses, and other health care professionals involved in the management of patients with multiple sclerosis.

 

This continuing education activity is provided by Vindico Medical Education.

Endorsed by The Consortium Of Multiple Sclerosis Centers Inc. (CMSC).

This activity is supported by educational grants from Biogen and Genentech, Inc.

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Vindico Medical Education is accredited as a provider of provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Vindico Medical Education will provide a maximum of 2.0 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of accredited content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be mitigated and disclosed to the activity audience.

Faculty, topics, program schedule, and credit hours are subject to change. Recording of any manner is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.

About Me

The Continuing Medical Education Program is an integral part of the organization’s overall mission which aims to improve learners’ competence and performance‐in‐practice and ultimately improve patient outcomes.

Related Posts